KYMR
KYMR
NASDAQ · Biotechnology

Kymera Therapeutics Inc

$99.45
+9.02 (+9.97%)
Analyst Consensus
Strong Buy
30
Analysts
Very High
Coverage
Buy 28 93%
Hold 2 7%
Sell 0 0%
Price Target
Analyst Price Target -68.8% upside
Low Target $20.33
Average Target $31.03
High Target $33.62
Current Price $99.45
Current
$99.45
Target
$31.03
$20.33 $31.03 avg $33.62
Scenario Analysis
Bear Case
$20.33
-79.6%
Low target
Base Case
$31.03
-68.8%
Avg target
Bull Case
$33.62
+-66.2%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$103.00
-3.4% from high
52-Week Low
$36.65
+171.4% from low
50-Day SMA
$78.66
+26.4% vs SMA
200-Day SMA
$56.03
+77.5% vs SMA
RSI (14)
77.3
Overbought
Target vs 52W High
$31.03
-69.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -37.5%